Clinical Trial Update: Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

View source ↗

Summary

The study aims to characterize clinical and immunogenetic features of Giant Cell Arteritis and Polymyalgia Rheumatica. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Polymyalgia Rheumatica

Snippet

Sponsor: University of Leeds | Conditions: Giant Cell Arteritis, Polymyalgia Rheumatica | Status: RECRUITING